title: PET/CT imaging in different types of lung cancer: an overview.
abstract: Lung cancer (LC) still represents one of the most common tumours in both women and men. PET/CT is a whole-body non-invasive imaging procedure that has been increasingly used for the assessment of LC patients. In particular, PET/CT added value to CT is mainly related to a more accurate staging of nodal and metastatic sites and to the evaluation of the response to therapy. Although the most common PET tracer for LC evaluation is 18F-FDG, new tracers have been proposed for the evaluation of lung neuroendocrine tumours (68Ga-DOTA-peptides, 18F-DOPA) and for the assessment of central nervous system metastasis (11C-methionine). This review focuses on the main clinical applications and accuracy of PET/CT for the detection of non-small cells lung cancer (NSCLC), broncho-alveolar carcinoma (BAC), small cells lung cancer (SCLC), lung neuroendocrine tumours (NET) and solitary pulmonary nodules (SPN).
authors: Department of Nuclear Medicine, Sant' Orsola-Malpighi Hospital, Bologna, Italy.
authors: Valentina
authors: V
authors: Ambrosini
authors: Silvia
authors: S
authors: Nicolini
authors: Paola
authors: P
authors: Caroli
authors: Cristina
authors: C
authors: Nanni
authors: Arianna
authors: A
authors: Massaro
authors: Maria Cristina
authors: MC
authors: Marzola
authors: Domenico
authors: D
authors: Rubello
authors: Stefano
authors: S
authors: Fanti
mesh_terms: D005260:Female; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D008175:Lung Neoplasms / Q000145:classification* / Q000175:diagnosis*; D008297:Male; D049268:Positron-Emission Tomography / Q000379:methods*; D013382:Subtraction Technique; D014057:Tomography, X-Ray Computed / Q000379:methods*